Expedited pathways: Breakthrough therapy designation, PRIME, and innovative licensing & access
Feature ArticlesMaurice Bancsi, PhD
Biologics/ biosimilars/ vaccinesEuropeNorth AmericaPharmaceuticalsFeature ArticlesMaurice Bancsi, PhDBiologics/ biosimilars/ vaccinesEuropeNorth AmericaPharmaceuticals